Why is Nath Bio-Genes falling/rising?

As of 04-Jul, Nath Bio-Genes (India) Ltd is experiencing a price increase, currently at Rs 215.95, reflecting a rise of Rs 6.2 or 2.96%. The stock has shown positive momentum, gaining 4.32% over the past week and 15.23% over the last month, significantly outperforming the Sensex, which has declined by 0.74% in the same week and increased by only 3.01% in the last month. Today's trading saw the stock open lower but quickly recovered, reaching an intraday high of Rs 217.05. The stock is trading above all key moving averages, indicating a bullish trend. Additionally, the stock's valuation appears attractive with a low Price to Book Value of 0.6, despite a negative return of -16.05% over the past year and declining profits.
In the broader market context, Nath Bio-Genes has outperformed the benchmark in the short term, particularly in the last week and month, while the Sensex has shown weaker performance. However, the stock has a history of underperformance over the longer term, with a significant decline of -16.05% in the past year and a poor return on capital employed. The company has faced challenges, including negative results in the last three quarters and weak long-term growth metrics, which may temper investor enthusiasm despite the recent gains. Overall, while the stock is rising in the short term, underlying fundamental weaknesses could pose risks for sustained growth.